SEC Tracker
Get the app

Accuray ARAY

Accuray appoints new director and approves key proposals

Form
8-K
Filed
Importance
Major
  1. Richard A. Meier appointed as Class II director on Oct 5, 2026
  2. Stockholders approved reverse stock split proposal with 74,331,147 votes for
  3. Company approved increase in authorized shares to 400M from 200M
  4. Nasdaq stock issuance proposal passed with 44,411,409 votes for

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Accuray files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Lucid Diagnostics LUCD public float $83M, Jun 30, 2025
  2. Fonar FONR
  3. Apyx Medical APYX public float $80M, Jun 30, 2025
  4. Microbot Medical MBOT public float $96M, Jun 30, 2025
  5. TELA Bio TELA public float $77M, Jun 30, 2025